Abstract

The incorporation of machine preservation technology into clinical solid-organ transplantation is becoming a routine procedure in many institutions around the globe. As experience with these modalities accrues over time, it is important to refine their application. In combination with laboratory based NMP experiments, early patient series allowed us to establish NMP viability criteria that were applied in the VITTAL trial.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call